Parkinson’s research and COVID-19
Parkinson’s won’t stop during this pandemic. Neither can the search for better treatments and a cure. We take a look at how research is moving forward during lockdown.
From finding out more about research to getting involved, there’s something for everyone.
- Results from a phase 2 clinical trial of a vaccine for Parkinson’s. We’re hearing a lot about vaccines in the news at the moment. And we’re learning that they take time to develop and test. But it isn’t just COVID-19 where a vaccine may be key to saving lives.
- Researchers identify a missing link in genetic Parkinson’s. The results of this Parkinson’s UK-funded study may help explain why some brain cells are more susceptible to Parkinson’s than others. The findings could open the door to new and better treatments.
- Have you completed Parkinson’s UK’s coronavirus survey yet? We’re working with researchers at Lancaster University to understand more about how people with Parkinson’s and their loved ones are affected by the coronavirus.
You can register to receive our research emails by visiting here and clicking on “Join the Network.”
By clicking on the link below you will be able to access a PDF file.